A cross-sectional study on substandard and falsified medicines (fake or counterfeit drugs) in UK pharmacies during the COVID-19 pandemic-Reference-Cited by-同舟云学术

A cross-sectional study on substandard and falsified medicines (fake or counterfeit drugs) in UK pharmacies during the COVID-19 pandemic

Published:2022-11-29 Issue: Volume: Page:1-11
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Barrett Ravina¹^ORCID

Affiliation:

1. Pharmacy Practice, School of Applied Sciences, Cockcroft Building, University of Brighton, Brighton, UK

Funder

Pharmacy Research UK/Research Training Bursary Level 1

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2023.2147922

Reference42 articles.

1. Medicines and Healthcare products Regulatory Agency. Implementing the falsified medicines directive: safety features [Internet]. GOV.UK. 2018 cited 2019 Jun 27]. Available from 2019 Jun 27: https://www.gov.uk/guidance/implementing-the-falsified-medicines-directive-safety-features.

2. Medicines and Healthcare products Regulatory Agency. Yellow card, making medicines and medical devices safer [Internet]. cited 2022 Oct 10]. Available from 2022 Oct 10: https://yellowcard.mhra.gov.uk/.

3. Under-Reporting of Adverse Drug Reactions

4. Evaluation of patient reporting of adverse drug reactions to the UK ‘Yellow Card Scheme’: literature review, descriptive and qualitative analyses, and questionnaire surveys

5. Adverse Drug Reaction Reporting in the UK

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring pharmacists' perspectives about substandard and falsified medical products through interviews;Exploratory Research in Clinical and Social Pharmacy;2024-03